Arbutus to Present at Chardan’s 6th Annual Genetic Medicines Conference
22 sept. 2022 07h30 HE
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop...